Events & Presentations
Close
Incyte International Locations
NORTH AMERICA—HEADQUARTERS
FINLAND
JAPAN
SWEDEN
EUROPE—HEADQUARTERS
FRANCE
THE NETHERLANDS
SWITZERLAND
AUSTRIA
GERMANY
NORWAY
UNITED KINGDOM
DENMARK
ITALY
SPAIN
Home > For Investors > ESMO 2019: Pemigatinib Development Update
Back
September 27, 2019
